ESHRE guidelines also recommend the use of GnRH agonists (nafarelin, leuprolide, buserelin, goserelin or triptorelin) as an option for reducing endometriosis-associated pain, although evidence is limited regarding dosage and duration of treatment (GRADE A) [1]. This evidence concerns the gene GNRH1 and endometriosis.